Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHESAT: Neuroblastoma Tumor Cell Vaccine
NCT00703222Phase 2Completed
- Sponsor
- Baylor College of Medicine
- Start
- Jun 2008
- Primary completion
- May 2011
- Modality
- Gene Editing, Gene Silencing, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of SJNB-JF-IL2, leptin, esketamine in neuroblastoma, sponsored by Baylor College of Medicine. Started Jun 2008; status: completed.
02
Drugs
SJNB-JF-IL2leptinesketamine
03
Conditions
neuroblastoma
Beyond the preview
Go deeper on NCT00703222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00703222.